Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Vapotherm Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
VAPO
Over the counter
3845
https://vapotherm.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Vapotherm Inc
Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT)
- Mar 20th, 2024 12:30 pm
Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE
- Mar 15th, 2024 11:36 am
Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherm's High Velocity Therapy effectively treats moderate-severe acute exacerbations of COPD, while improving patient comfort
- Mar 6th, 2024 11:45 am
Vapotherm's HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South America's Largest Health Care Market
- Feb 29th, 2024 11:45 am
Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results
- Feb 22nd, 2024 9:10 pm
OTC Markets Group Welcomes Vapotherm, Inc. to OTCQX
- Dec 15th, 2023 12:00 pm
Vapotherm Announces Suspension of NYSE Listing Common Stock Expected to Begin Trading Promptly on OTCQX
- Dec 14th, 2023 11:27 pm
Vapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock Application Pending to Transfer Shares to OTCQX
- Dec 11th, 2023 11:45 am
Vapotherm Educates over 8,000 Clinicians in Respiratory Care Month
- Nov 28th, 2023 9:54 pm
Vapotherm, Inc. (NYSE:VAPO) Q3 2023 Earnings Call Transcript
- Nov 10th, 2023 4:16 pm
Vapotherm Reports Third Quarter 2023 Financial Results
- Nov 8th, 2023 9:10 pm
3 Stocks Set to Rocket When the Bears Get Short-Squeezed
- Nov 2nd, 2023 6:34 pm
Vapotherm To Report Third Quarter 2023 Financial Results
- Nov 1st, 2023 10:45 am
Computational Fluid Dynamics (CFD) modeling further distinguishes Vapotherm High Velocity Therapy from generic high flow cannulas
- Oct 4th, 2023 10:45 am
Pilot Study demonstrates Vapotherm HVNI technology is more effective than standard oxygen therapy for treatment of acute asthma in children
- Sep 25th, 2023 10:45 am
Insider Buying: Vapotherm Inc's President and CEO Joseph Army Acquires 100,000 Shares
- Sep 12th, 2023 5:02 am
Vapotherm (VAPO) Reports Q2 Loss, Misses Revenue Estimates
- Aug 8th, 2023 11:30 pm
Vapotherm Reports Second Quarter 2023 Financial Results
- Aug 8th, 2023 8:10 pm
Vapotherm To Report Second Quarter 2023 Financial Results
- Jul 25th, 2023 8:30 pm
Vapotherm (VAPO) Reports Q1 Loss, Lags Revenue Estimates
- May 3rd, 2023 11:15 pm
Scroll